PPT Slide

Oral Recombinant Human Growth Hormone Program

• Indication

  • Treatment of growth hormone deficiency

• Marketed dosage form

  • Subcutaneous injection

• Physicochemical property

  • Protein with 191 amino acids
  • Molecular weight of 22,125 daltons

• Project objective

  • Assess the viability of delivering growth hormone orally using eligen™ delivery technology

Previous slide

Next slide

Back to first slide

View graphic version